...

Journal Options HIV

Course Directors: Joseph J. Eron, Jr., MD, William G. Powderly, MD, Andrew R. Zolopa, MD

Browse Journal Options by Topic

View Collections

Featured Expert Commentary

Still Searching for Answers on HAART Timing in TB Patients

Timothy R. Sterling, MD

Timothy R. Sterling, MD

Professor of Medicine
Division of Infectious Diseases
Vanderbilt University School of Medicine
Nashville, Tennessee

Recent Articles

  • Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

    Emery S, Neuhaus JA, Phillips AN, et al, for the SMART Study Group.

    J Infect Dis. 2008;197:1133-1144.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Hepatotoxicity of Antiretroviral Drugs Is Reduced After Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients.

    Labarga P, Soriano V, Vispo ME, et al.

    J Infect Dis. 2007;196:670-676.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.

    Lundgren JD, Babiker A, El-Sadr W, et al, for the SMART Study Group.

    J Infect Dis. 2008;197:1145-1155.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.

    McComsey GA, Re VL 3rd, O'Riordan M, et al.

    Clin Infect Dis. 2008;46:1290-1296.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

    Patel P, Hanson DL, Sullivan PS, et al.

    Ann Intern Med. 2008;148:728-736.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.

    Ribaudo HJ, Kuritzkes DR, Lalama CM, et al.

    J Infect Dis. 2008;197:1006-1010.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Class-sparing regimens for initial treatment of HIV-1 infection.

    Riddler SA, Haubrich R, DiRienzo AG, et al.

    New Engl J Med. 2008;358:2095-2106.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

    Sabin CA, Worm SW, Weber R, et al, for the D:A:D Study Group.

    Lancet. 2008;371:1417-1426.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Durability and Outcome of Initial Antiretroviral Treatments Received during 2000-2005 by Patients in the Swiss HIV Cohort Study.

    Vo TT, Ledergerber B, Keiser O, et al.

    J Infect Dis. 2008;197:1685-1694.

    Capsule Summary | Expert Commentary | Abstract | Slides

  • Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.

    Crum-Cianflone N, Hullsiek KH, Marconi V, et al.

    AIDS. 2009;23:41-50.

    Capsule Summary | Expert Commentary | Abstract | Slides

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.

Volume 5, Issue 2 Collection

HIV Journal Options – Volume 5, Issue 2 CME



Program Directors: Joseph J. Eron, Jr., MD, William G. Powderly, MD, Andrew R. Zolopa, MD

Faculty:

Keith Henry, MDPaul Krogstad, MDKristine Patterson, MD
  • Keith Henry, MD
  • Paul Krogstad, MD
  • Kristine Patterson, MD
Amanda Peppercorn, MDGerald Pierone, Jr. , MDPaul E. Sax, MD
  • Amanda Peppercorn, MD
  • Gerald Pierone, Jr. , MD
  • Paul E. Sax, MD
Timothy R. Sterling, MDTimothy Wilkin, MD, MPH
  • Timothy R. Sterling, MD
  • Timothy Wilkin, MD, MPH

Abstract

CREDIT INFORMATION

Release Date: 06/23/09

Expiration Date: 06/22/10


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Volume 5, Issue 1 Collection

HIV Journal Options – Volume 5, Issue 1



Program Directors:

Joseph J. Eron, Jr., MDWilliam G. Powderly, MDAndrew R. Zolopa, MD
  • Joseph J. Eron, Jr., MD
  • William G. Powderly, MD
  • Andrew R. Zolopa, MD

Faculty: Ian Frank, MD, P. Richard Harrigan, PhD, Charles B. Hicks, MD, Patrick W.G. Mallon, MB, BCh, FRACP, Michael Mugavero, MD, MHSc, James H. Stein, MD, Babafemi Taiwo, MBBS, Charles van der Horst, MD

Abstract

CREDIT INFORMATION

Release Date: 03/05/09

Expiration Date: 03/04/10


Physicians: maximum of 1.0 AMA PRA Category 1 Credit